1007/s00125-007-0684-2.

Risk of suicidal behavior smoking cessation drug and an increased risk of self-harm or depressionNew research on bmj.com today it suggests no strong evidence that the popular smoking cessation drug varenicline of self-harm of self-harm or depression compared to other cessation products.

The participants were nicotine replacement products or bupropion .It was a review of all electronic patient records over the period of the prescription and for three months after the date of the last prescription. Incidence of fatal and non – fatal self-harm, suicidal ideation and depression studied.Dr. Ceriello ‘Reactive oxygen species communicate one cellular ‘memory’ which high glucose stressful signaling’the paper is in Diabetologia in Diabetologia DOI 10.1007/s00125-007-0684-2. Said second paper, published to Diabetescare be example, be entitled ‘antioxidant and free radical, endothelial dysfunction, oxidative and nitrosative stress ‘and does his work with the AT-1 receptor blockers telmisartan.